NO20060781L - Anvendelse av loselig CD164 ved inflammatoriske og/eller autoimmune lidelser - Google Patents

Anvendelse av loselig CD164 ved inflammatoriske og/eller autoimmune lidelser

Info

Publication number
NO20060781L
NO20060781L NO20060781A NO20060781A NO20060781L NO 20060781 L NO20060781 L NO 20060781L NO 20060781 A NO20060781 A NO 20060781A NO 20060781 A NO20060781 A NO 20060781A NO 20060781 L NO20060781 L NO 20060781L
Authority
NO
Norway
Prior art keywords
inflammatory
autoimmune disorders
soluble
human
treatment
Prior art date
Application number
NO20060781A
Other languages
English (en)
Inventor
Yolande Chvatchko
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20060781L publication Critical patent/NO20060781L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Transplantation (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Det beskrives nye terapeutiske anvendelser av oppløselige proteiner omfattende det ekstracellulære område av human CD 164, særlig for behandling av infiammatoriske og/eller autoimmune forstyrrelser.
NO20060781A 2003-07-23 2006-02-17 Anvendelse av loselig CD164 ved inflammatoriske og/eller autoimmune lidelser NO20060781L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03077316 2003-07-23
PCT/EP2004/051596 WO2005011728A2 (en) 2003-07-23 2004-07-23 Use of soluble cd164 in inflammatory and/or autoimmune disorders

Publications (1)

Publication Number Publication Date
NO20060781L true NO20060781L (no) 2006-03-17

Family

ID=34112463

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060781A NO20060781L (no) 2003-07-23 2006-02-17 Anvendelse av loselig CD164 ved inflammatoriske og/eller autoimmune lidelser

Country Status (15)

Country Link
US (2) US20060257402A1 (no)
EP (1) EP1646396A2 (no)
JP (1) JP4705028B2 (no)
KR (1) KR20060106810A (no)
CN (1) CN1845752A (no)
AR (1) AR045074A1 (no)
AU (1) AU2004260835A1 (no)
BR (1) BRPI0412243A (no)
CA (1) CA2532870A1 (no)
EA (1) EA009389B1 (no)
IL (1) IL173197A0 (no)
NO (1) NO20060781L (no)
RS (1) RS20060023A (no)
WO (1) WO2005011728A2 (no)
ZA (1) ZA200600193B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006207471A1 (en) * 2005-01-24 2006-07-27 Laboratoires Serona S.A. Use of soluble CD164 variants in inflammatory and/or autoimmune disorders
ES2426069T3 (es) 2007-02-12 2013-10-21 A1M Pharma Ab Diagnóstico de preeclampsia
EP2313106B1 (en) 2008-07-18 2016-03-30 A1M Pharma AB Medical use of the radical scavenger and antioxidant alpha-1-microglobulin
US8392585B1 (en) * 2011-09-26 2013-03-05 Theranos, Inc. Methods and systems for facilitating network connectivity
WO2022099695A1 (en) * 2020-11-16 2022-05-19 Jiangsu Cell Tech Medical Research Institute Co., Ltd. Cd164 fusion and uses thereof
CN114891107A (zh) * 2022-05-12 2022-08-12 北京农学院 一种抗猪cd164l2单克隆抗体制备与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
WO2002098917A2 (en) * 2001-02-12 2002-12-12 Curagen Corporation Human proteins and nucleic acids encoding same

Also Published As

Publication number Publication date
EP1646396A2 (en) 2006-04-19
US8075894B2 (en) 2011-12-13
EA200600314A1 (ru) 2006-06-30
RS20060023A (sr) 2008-06-05
IL173197A0 (en) 2006-06-11
US20090285838A1 (en) 2009-11-19
KR20060106810A (ko) 2006-10-12
BRPI0412243A (pt) 2006-09-19
JP4705028B2 (ja) 2011-06-22
ZA200600193B (en) 2007-04-25
CA2532870A1 (en) 2005-02-10
US20060257402A1 (en) 2006-11-16
WO2005011728A3 (en) 2005-06-02
CN1845752A (zh) 2006-10-11
AU2004260835A1 (en) 2005-02-10
WO2005011728A2 (en) 2005-02-10
AR045074A1 (es) 2005-10-12
EA009389B1 (ru) 2007-12-28
JP2006528159A (ja) 2006-12-14

Similar Documents

Publication Publication Date Title
BR0214309A (pt) Derivados aril-1,4-pirazina substituìdos
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
EP1764370A3 (en) Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
NO20061736L (no) Krystallform av epotilon B
TW200732347A (en) VEGF analogs and methods of use
DE60314603D1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
WO2006121610A3 (en) Personal care compositions and methods for their use
MXPA02012743A (es) Moleculas tipo il-17 y usos de las mismas.
NO20053855L (no) 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer.
TNSN07036A1 (en) Human monoclonal antibodies against human il-4
DK2172208T3 (da) Små peptider til behandling af alzheimers sygdom og andre beta-amyloidprotein- fibrillogeneseforstyrrelser
ATE450622T1 (de) Gene und proteine für verhinderung, vorhersage, prognose und therapie der herzgefäss-krankheit
NO20055741L (no) Nye kjemiske forbindelser
SE0302304D0 (sv) Novel compounds
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole
TR200200278T2 (tr) Kalsilitik bileşimler
TW200503717A (en) Substituted 1,4-pyrazine derivatives
PL374550A1 (en) Il-17 like molecules and uses thereof
WO2005044244A3 (de) Verwendung von mrp4-inhibitoren zur behandlung und/oder prophylaxe kardiovaskulärer erkrankungen
EA200600314A1 (ru) Использование растворимого cd164 при воспалительных и/или аутоимунных нарушениях
NO20060420L (no) 2-aminobenzoylderivater
IS7868A (is) Notkun á kortkólíberín-úrókortín kerfi í meðferð á bólguvaldandi sjúkdómum.
SE0202608D0 (sv) New sequences
NO20053247L (no) Anvendelse av levocetirizin ved behandling av vedvarende allergisk rhinitt.

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA, 0125 OSLO, NO

FC2A Withdrawal, rejection or dismissal of laid open patent application